Featured Research

from universities, journals, and other organizations

Diabetes Therapy May Impair Memory Function In Children

Date:
October 7, 1999
Source:
Washington University In St. Louis
Summary:
Researchers from Washington University School of Medicine in St. Louis and the University of Washington in Seattle have found evidence of slight memory impairment in children receiving intensive therapy (IT) for insulin-dependent diabetes.

Researchers from Washington University School of Medicine in St. Louis and the University of Washington in Seattle have found evidence of slight memory impairment in children receiving intensive therapy (IT) for insulin-dependent diabetes.

Reporting in the August 1999 edition of the journal Diabetes Care, the investigators said such children have three times the risk for severe hypoglycemia (low blood glucose) and a slight decline in performance on a test to measure spatial memory function. The research was supported in part by grants from the Juvenile Diabetes Foundation and the U.S. Public Health Service.

Most diabetes experts now recommend IT for patients with diabetes because the nationwide Diabetes Control and Complications Trial (DCCT) showed that intensive therapy could keep patients healthier longer. The DCCT concluded that by keeping blood glucose levels within a narrow window, intensive therapy could delay the onset of the major complications of diabetes: vision loss, nerve problems and kidney failure.

But the DCCT also found that as patients worked to keep glucose levels under tighter control, they increased the risk that those levels would fall too low. Adults and adolescents on IT had an increased risk of severe hypoglycemia, which can cause weakness, confusion and loss of consciousness and, in the worst cases, seizures or coma. This new study found a similar elevated risk in children.

Tracking hypoglycemic events

The Washington University investigators studied 25 children with insulin-dependent diabetes. Of those, 13 were randomly assigned to receive intensive therapy. They were expected to measure their blood glucose at least four times each day and use three to four insulin injections or an insulin pump to control their blood glucose levels.

The other 12 children received the older, conventional diabetes therapy. They checked blood glucose two to four times each day and used one or two insulin injections.

Those children -- and 16 control subjects who did not have diabetes -- were followed for two years. Every time a child in the study had a severe hypoglycemic episode, the parents were required to report it to the nurses. "At the end of two years, kids in the IT group had a three-fold higher rate of severe hypoglycemic incidents, though not every child had such an incident," said Tamara Hershey, Ph.D., the paper's lead author and a postdoctoral fellow in psychiatry at Washington University School of Medicine.

Because a person with diabetes is unlikely to check glucose levels in the midst of a hypoglycemic episode, the researchers couldn't define severe hypoglycemia according to measurable glucose levels. So they used the DCCT definition of severe hypoglycemia. An episode was severe if the patient needed outside assistance to stabilize blood glucose or if a doctor or parent or friend had to administer glucagon or help in some other way.

Memory testing

After two years of diabetes therapy, the children took a battery of tests to measure cognitive function. One test measured a brain function called spatial declarative memory. "They sat at a computer screen, and a dot would appear," Hershey explained. "After a certain period of time, they had to point to the screen where they remembered seeing the dot."

With assistance from a computer, the researchers determined the child's accuracy. As waiting times increased, children on IT showed greater impairment than children on conventional diabetes therapy. "Their impairment showed a particular pattern, but it was very slight," Hershey said. "You wouldn't have noticed as the children went about their daily routines."

But she believes the impairment may signal problems related to severe hypoglycemia. Past research has shown that hypoglycemia can damage neurons. And hypoglycemic episodes selectively, although not exclusively, impair neuronal function in the brain's hippocampus, a seahorse-shaped structure important in memory and learning. Hershey also says there can be damage in structures that surround the hippocampus in an area of the brain known as the medial-temporal region.

"Neurons there are affected by severe hypoglycemia, and they can die," she said. "If you have repeated insults, more and more neurons may die. Over time, there may be behavioral consequences."

Without more research, Hershey isn't ready to call the observed impairment in spatial declarative memory a consequence of severe hypoglycemia. But she was careful during the study to make sure that children were not hypoglycemic during the testing. She wanted to learn whether there are any long-term or permanent consequences related to hypoglycemia rather than whether the brain functions differently when a child is hypoglycemic.

"We really don't know how severe hypoglycemia may or may not affect cognitive functioning in children, but our data are so preliminary that we're very careful not to suggest that intensive therapy be ruled out for children because of potential cognitive effects," Hershey said. "I think IT has a lot of benefits for adults and adolescents, and it may have those benefits in children too."

On the other hand, Hershey and colleagues want to make sure the benefits outweigh the potential risks. Currently, she is studying a larger group of children with diabetes to learn both whether the effects on spatial declarative memory will be detectable in that larger group and whether certain effects might correspond with clinical symptoms -- whether memory changes might relate to the number of severe hypoglycemic episodes a child has. That study will take another few years to complete.


Story Source:

The above story is based on materials provided by Washington University In St. Louis. Note: Materials may be edited for content and length.


Cite This Page:

Washington University In St. Louis. "Diabetes Therapy May Impair Memory Function In Children." ScienceDaily. ScienceDaily, 7 October 1999. <www.sciencedaily.com/releases/1999/10/991007083837.htm>.
Washington University In St. Louis. (1999, October 7). Diabetes Therapy May Impair Memory Function In Children. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/1999/10/991007083837.htm
Washington University In St. Louis. "Diabetes Therapy May Impair Memory Function In Children." ScienceDaily. www.sciencedaily.com/releases/1999/10/991007083837.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
New Drug Could Reduce Cardiovascular Deaths

New Drug Could Reduce Cardiovascular Deaths

Newsy (Aug. 30, 2014) The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins